Close

Valeant Pharma (VRX) to Acquire Salix Pharma (SLXP) in $14.5B Deal

February 22, 2015 4:29 PM EST Send to a Friend
Valeant Pharma (NYSE: VRX) and Salix Pharmaceuticals, Ltd. (Nasdaq: SLXP) announced that they have entered into a definitive agreement under ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login